Found 4 matching trials
Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma
PHASE2Ofatumumab is a drug that works by attaching to the CD20 molecule found on ...
Location
Massachusetts General Hospital
A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia
PHASE2This is an open-label study to evaluate tolerability, safety, efficacy and ...
Location
GSK Investigational Site
Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia
PHASE3The purpose of this study was to evaluate the safety and efficacy of ofatum...
Location
Novartis Investigative Site
A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia
PHASE2Ofatumumab is an IgG1Îș fully human monoclonal antibody (mAb) that specifica...
Location
GSK Investigational Site